Yan Yu Selected Research

Adenocarcinoma of Lung

8/2023	The significance of spread through air spaces in the prognostic assessment model of stage I lung adenocarcinoma and the exploration of its invasion mechanism.
1/2023	Sec61γ is a vital protein in the endoplasmic reticulum membrane promoting tumor metastasis and invasion in lung adenocarcinoma.
1/2022	Comprehensive analysis for clarifying transcriptomics landscapes of spread through air spaces in lung adenocarcinoma.
1/2022	RNA-binding motif protein 10 represses tumor progression through the Wnt/β- catenin pathway in lung adenocarcinoma.
1/2022	IL7R Is Correlated With Immune Cell Infiltration in the Tumor Microenvironment of Lung Adenocarcinoma.
12/2021	Value and significance of brain radiation therapy during first-line EGFR-TKI treatment in lung adenocarcinoma with EGFR sensitive mutation and synchronous brain metastasis: Appropriate timing and technique.
1/2021	Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data.
1/2021	CXCR1 correlates to poor outcomes of EGFR-TKI against advanced non-small cell lung cancer by activating chemokine and JAK/STAT pathway.
10/2020	Resveratrol modulates the apoptosis and autophagic death of human lung adenocarcinoma A549 cells via a p53‑dependent pathway: Integrated bioinformatics analysis and experimental validation.
9/2020	FAM83A drives PD-L1 expression via ERK signaling and FAM83A/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan Yu Research Topics

Disease

174	Neoplasms (Cancer) 04/2024 - 11/2002
45	Neoplasm Metastasis (Metastasis) 12/2023 - 11/2002
38	Sepsis (Septicemia) 01/2022 - 04/2002
37	Infections 02/2024 - 11/2003
36	Inflammation (Inflammations) 02/2024 - 07/2006
35	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 07/2011
32	Burns 02/2017 - 04/2002
23	Lung Neoplasms (Lung Cancer) 08/2023 - 09/2007
21	Leukemia 12/2023 - 08/2008
18	Fibrosis (Cirrhosis) 04/2024 - 07/2011
18	Adenocarcinoma of Lung 08/2023 - 06/2009
17	Spinal Cord Injuries (Spinal Cord Injury) 02/2024 - 04/2014
15	Hemorrhage 02/2024 - 12/2015
15	Wounds and Injuries (Trauma) 10/2023 - 07/2002
15	Stroke (Strokes) 12/2022 - 05/2012
14	Hypoxia (Hypoxemia) 01/2025 - 02/2009
13	Body Weight (Weight, Body) 03/2024 - 11/2010
13	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 05/2012
13	Carcinogenesis 01/2022 - 01/2012
12	Breast Neoplasms (Breast Cancer) 08/2023 - 06/2007
12	Pneumonia (Pneumonitis) 06/2023 - 01/2021
10	Pain (Aches) 03/2024 - 05/2007
10	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 09/2006
9	Melanoma (Melanoma, Malignant) 01/2021 - 09/2008
8	Atrophy 02/2024 - 01/2017
8	Adenocarcinoma 09/2023 - 01/2006
8	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 01/2012
8	Multiple Organ Failure (MODS) 01/2022 - 04/2003
8	Stomach Neoplasms (Stomach Cancer) 12/2021 - 05/2011
8	Carcinoma (Carcinomatosis) 01/2021 - 01/2006
8	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 12/2005
7	Ischemia 04/2024 - 01/2011
7	Brain Neoplasms (Brain Tumor) 02/2024 - 01/2016
7	Virus Diseases (Viral Diseases) 01/2024 - 03/2008
7	Hypertension (High Blood Pressure) 01/2024 - 05/2012
7	Disease Progression 12/2023 - 04/2013
7	Chronic Obstructive Pulmonary Disease (COPD) 10/2023 - 07/2016
7	Ovarian Neoplasms (Ovarian Cancer) 10/2022 - 03/2008
7	Critical Illness (Critically Ill) 04/2022 - 01/2011
7	Diarrhea 05/2019 - 11/2010
7	Necrosis 12/2018 - 12/2008
7	Mucositis 06/2015 - 11/2010
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2024 - 07/2015
6	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 01/2007
6	Cicatrix (Scar) 01/2024 - 01/2010
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2023 - 06/2009
6	Brain Ischemia (Cerebral Ischemia) 11/2023 - 01/2008
6	COVID-19 07/2023 - 11/2020
6	Tuberculosis (Tuberculoses) 01/2023 - 01/2015

Drug/Important Bio-Agent (IBA)

69	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2002
49	Messenger RNA (mRNA)IBA 01/2025 - 04/2002
37	HMGB1 Protein (HMG1)IBA 01/2019 - 03/2003
35	Biomarkers (Surrogate Marker)IBA 02/2024 - 07/2011
31	CytokinesIBA 12/2024 - 11/2003
20	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 04/2002
19	RNA (Ribonucleic Acid)IBA 01/2025 - 11/2002
18	Therapeutic UsesIBA 10/2023 - 11/2010
17	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 05/2006
13	MicroRNAs (MicroRNA)IBA 01/2023 - 05/2011
12	CollagenIBA 04/2024 - 02/2007
12	Citric Acid (Citrate)FDA LinkGeneric 12/2023 - 12/2015
12	salicylhydroxamic acid (SHAM)IBA 01/2023 - 04/2003
12	EnzymesIBA 01/2022 - 01/2009
11	Long Noncoding RNAIBA 01/2024 - 01/2017
11	SodiumIBA 01/2023 - 08/2013
11	Interleukin-6 (Interleukin 6)IBA 01/2022 - 02/2015
10	LipidsIBA 01/2024 - 01/2012
10	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2023 - 08/2008
10	LipopolysaccharidesIBA 01/2023 - 04/2002
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2024 - 03/2008
9	PlatinumIBA 03/2024 - 07/2011
9	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 01/2006
9	Interleukin-17 (Interleukin 17)IBA 06/2023 - 01/2015
9	Interleukin-2 (IL2)IBA 01/2021 - 12/2004
9	AntigensIBA 11/2019 - 05/2005
8	Small Interfering RNA (siRNA)IBA 01/2024 - 12/2007
8	Indicators and Reagents (Reagents)IBA 01/2023 - 11/2002
8	SaltsIBA 12/2022 - 12/2018
8	EndotoxinsIBA 02/2008 - 04/2002
7	Peptides (Polypeptides)IBA 01/2024 - 03/2008
7	AntibodiesIBA 05/2023 - 05/2014
7	Interleukin-10 (Interleukin 10)IBA 11/2022 - 07/2004
7	Fluorouracil (Carac)FDA LinkGeneric 06/2015 - 11/2010
6	Glucose (Dextrose)FDA LinkGeneric 01/2025 - 01/2008
6	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 01/2015
6	Insulin (Novolin)FDA Link 03/2024 - 12/2003
6	LigandsIBA 02/2024 - 12/2015
6	Tyrosine Kinase InhibitorsIBA 12/2023 - 01/2015
6	Formaldehyde (Formol)FDA Link 12/2022 - 05/2007

Therapy/Procedure

78	Therapeutics 04/2024 - 09/2005
57	Drug Therapy (Chemotherapy) 02/2024 - 11/2010
24	Radiotherapy 01/2024 - 01/2009
16	Continuous Renal Replacement Therapy 12/2022 - 08/2013
14	Immunotherapy 04/2024 - 03/2013
13	Ligation 01/2023 - 03/2003
10	Brachytherapy 12/2023 - 09/2006
9	Punctures 01/2020 - 03/2003
7	Transplantation 04/2023 - 04/2014
7	Catheters 11/2020 - 01/2010
7	Resuscitation 01/2020 - 01/2005